Suggestions
Michael Arlotto
Founder at Remarque Systems
Professional Background
With an impressive career spanning over 25 years, Michael Arlotto has established himself as a pivotal leader in the pharmaceutical, biotechnology, and healthcare IT industries. His deep understanding of key business drivers and operational excellence has allowed him to navigate complex market environments successfully, creating unmatched value throughout his career. Michael's leadership journey began with a solid foundation in toxicology, which paved the way for his transition into strategic management, corporate development, and operational innovation.
Michael currently serves as the Founder and CEO of Remarque Systems, where he is dedicated to transforming health data into actionable insights. He utilizes his extensive background in life sciences and operational management to spearhead innovative solutions that drive the industry forward. His deep understanding of the pharmaceutical landscape has positioned Remarque Systems as a leader in providing analytical services to optimize clinical development processes.
Before founding Remarque Systems, Michael was the Managing Director at Arlotto Strategic Services, LLC, where he advised organizations on strategic growth and operational efficiency. His notable performance while leading various corporate divisions at Quintiles Transnational Corp further solidified his reputation as a forward-thinking leader. In fact, during his tenure at Quintiles, he held several high-ranking positions, including Global Vice President of Corporate Development, Senior Vice President of NovaQuest, and Senior Vice President of Project Management in Clinical Development Services.
Education and Achievements
Michael's academic journey began with a Bachelor of Science degree in Toxicology from the University of the Sciences in Philadelphia, where he laid the groundwork for his expertise in the biological sciences. He furthered his education by acquiring a PhD in Toxicology at the University of Kansas School of Medicine. This comprehensive educational background equipped him with critical scientific insights, which he applied as he ventured into the corporate world.
One of Michael's significant contributions to the industry was his role on the Board of Directors for GeneScreen Inc., highlighting his commitment to advancing scientific development through effective leadership. His work in various capacities within Quintiles Transnational Corp—ranging from Senior Director of Corporate Planning & Business Integration to Vice President of Strategic Planning and Risk Management—demonstrates his capability in guiding teams toward achieving strategic objectives and enhancing client satisfaction.
Michael also excelled as a Senior Research Scientist at Bayer Pharmaceuticals, where he played a crucial role in developing innovative pharmaceutical products. His industry influence extends to the FDA, where he served as an Oak Ridge University Post-doctoral Fellow, further enriching his understanding of regulatory frameworks and safety assessments essential in drug development.
Achievements
Michael Arlotto has a proven track record of delivering results that speak volumes about his capability and dedication. His leadership principles have not only shaped organizational strategies but have also catalyzed remarkable growth trajectories for the companies he has been involved with. At Quintiles, under his leadership, tremendous advancements were made in the realms of clinical development services and risk management strategies, demonstrating his ability to leverage scientific expertise for tangible business success.
His extensive experience in both the operational and scientific realms positions him uniquely in fostering collaborations that are essential for the advancement of Pharmaceutical Services. Also, as the founder and CEO of Remarque Systems, Michael has continued to make a significant impact on the healthcare landscape by focusing on how data can be harnessed to improve patient outcomes and streamline industry processes.
In summary, Michael Arlotto is a dynamic and sought-after leader in the pharmaceutical and biotechnology sectors. His extensive background in toxicology, combined with years of operational leadership experience, continues to propel innovations that benefit the industry at large.
